Trials / NCT01560715
Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa
Completed Phase 2 Cell therapy
- Sponsor
- University of Sao Paulo
- Treatment
- intravitreal injection of autologous bone marrow stem cells
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to 75 Years
- Enrollment
- 50 participants
- Started
- 2011-06
- Main results expected
- 2013-01
- Results posted
- Not yet
- Record last updated
- 2017-07-21
What the study is testing
The purpose of this study is to evaluate the short-term safety and efficacy of a single intravitreal injection of autologous bone marrow stem cells in patients with retinitis pigmentosa.
Where it runs
Brazil (1)
- Centro de Pesquisa Rubens Siqueira, São José do Rio Preto, São Paulo